Daniella Rylander Ottosson

Predictive Markers Guide Differentiation to Improve Graft Outcome in Clinical Translation of hESC-Based Therapy for Parkinson’s Disease

Agnete Kirkeby, Sara Nolbrant, Katarína Tiklová et al. · Cell stem cell · 2016 · 266 citations · Full text

Graft Outcome, Neurochemical Biomarkers, Translational Advance +21

Maladaptive plasticity of serotonin axon terminals in levodopa‐induced dyskinesia

Daniella Rylander Ottosson, Martin Parent, Sean S. O’Sullivan et al. · Annals of Neurology · 2010 · 248 citations

In Vivo Reprogramming of Striatal NG2 Glia into Functional Neurons that Integrate into Local Host Circuitry

Olof Torper, Daniella Rylander Ottosson, Maria Pereira et al. · Cell Reports · 2015 · 200 citations · Full text

Pharmacological Modulation of Glutamate Transmission in a Rat Model of l-DOPA-Induced Dyskinesia: Effects on Motor Behavior and Striatal Nuclear Signaling

Daniella Rylander Ottosson, Alessandra Recchia, F Mela et al. · Journal of Pharmacology and Experimental Therapeutics · 2009 · 170 citations · Full text

A mGluR5 antagonist under clinical development improves L-DOPA-induced dyskinesia in parkinsonian rats and monkeys

Daniella Rylander Ottosson, Hanna Iderberg, Qin Li et al. · Neurobiology of Disease · 2010 · 149 citations · Full text

Mglur5 Antagonist, Medicine, Functional Selectivity +8